卵巢内雄激素预处理对博洛尼亚标准低反应患者卵巢储备参数的影响
本开放标签试点研究纳入30例符合博洛尼亚标准的低反应患者,接受8周卵巢内雄激素预处理后行IVF。预处理后睾酮、孕酮、雌二醇和HCG水平无变化,AMH从0.49 ng/ml降至0.33 ng/ml,AFC维持4-5,获1.1±0.9枚可移植胚胎,15例移植,无持续妊娠。
要点
- 长期卵巢内雄激素预处理未显著改变激素水平、AFC及可募集卵泡。
- AMH从基线0.49 ng/ml降至8周时0.33 ng/ml。
- 获平均1.1±0.9枚可移植胚胎,15例移植,无持续妊娠。
核心结论
- 当前方案长期卵巢内雄激素预处理对博洛尼亚标准低反应患者的激素水平、AFC及刺激后可募集卵泡无显著影响。
- 需进一步研究其他雄激素预处理方案及预处理在IVF中的临床价值。
研究设计与样本
- 开放标签试点研究,在越南胡志明市IVFMD、My Duc医院进行。
- 纳入连续30例年龄18-41岁、符合博洛尼亚标准低反应、接受卵巢内雄激素预处理及超长降调节后行IVF的患者。
主要发现
- 预处理期间循环睾酮、孕酮、雌二醇和HCG水平保持不变。
- 平均AMH从基线0.49 ng/ml稳步下降至8周时0.33 ng/ml。
- 研究全程AFC为4-5。
- 平均获1.1±0.9枚可移植胚胎,15例患者行胚胎移植,未获持续妊娠。
关键数值与推荐
- 预处理方案:低剂量重组人绒毛膜促性腺激素(rHCG)260 IU隔日一次联合来曲唑2.5 mg/天,均用8周,至卵巢刺激第一天停止。
- 主要终点为预处理8周后血清抗苗勒管激素(AMH)浓度。
- 次要终点包括窦卵泡计数(AFC,2-10 mm)、血清HCG、睾酮和孕酮水平。
临床怎么用
- 当前卵巢内雄激素预处理方案未显示对博洛尼亚标准低反应患者卵巢储备参数或IVF结局的获益。
- 临床不应常规采用该方案,需等待更多研究探索其他预处理方案。
局限性
- 开放标签试点研究,样本量小(n=30),无对照组。
- 未获持续妊娠,无法评估临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What are the effects of long-term androgen priming in Bologna criteria poor ovarian reserve (POR) patients undergoing IVF? DESIGN: This open-label pilot study was conducted at IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam. It included consecutive patients aged 18-41 years who fulfilled Bologna criteria for POR undergoing intra-ovarian androgen priming and ultra-long down-regulation with a gonadotrophin-releasing hormone agonist (GnRHa), followed by stimulation with gonadotrophins and GnRH antagonist co-treatment for IVF (n = 30). Priming consisted of low-dose recombinant human chorionic gonadotrophin (rHCG) 260 IU every second day plus letrozole 2.5 mg/day, both for 8 weeks; priming stopped on the first day of ovarian stimulation. The primary endpoint was serum anti-Müllerian hormone (AMH) concentration 8 weeks after priming. Secondary endpoints included antral follicle count (AFC) (2-10 mm), serum human chorionic gonadotrophin (HCG), testosterone and progesterone levels. RESULTS: Circulating testosterone, progesterone, oestradiol and HCG levels remained unchanged during androgen priming; the mean AMH level decreased steadily from 0.49 ng/ml (baseline) to 0.33 ng/ml (8 weeks). AFC was 4-5 throughout the study. A mean of 1.1 ± 0.9 good transferable embryos were obtained; embryo transfer was performed in 15 patients; no ongoing pregnancies were obtained. CONCLUSIONS: Long-term intra-ovarian androgen priming in the current set-up had no significant effect on hormone levels, AFC and recruitable follicles after ovarian stimulation in Bologna POR patients undergoing IVF. Further studies are needed to explore other androgen priming protocols and the clinical value of priming regimens in IVF.
引用
- Vuong LN, Ho TM, Ha AN, et al. The effect of intra-ovarian androgen priming on ovarian reserve parameters in Bologna poor responders. Reprod Biomed Online. 2019. PMID: 31974029. doi:10.1016/j.rbmo.2019.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。